MN-001 BID + MN-001 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Interstitial Cystitis
Conditions
Interstitial Cystitis
Trial Timeline
May 1, 2005 → Oct 1, 2006
NCT ID
NCT00295854About MN-001 BID + MN-001 + Placebo
MN-001 BID + MN-001 + Placebo is a phase 2 stage product being developed by MediciNova for Interstitial Cystitis. The current trial status is completed. This product is registered under clinical trial identifier NCT00295854. Target conditions include Interstitial Cystitis.
What happened to similar drugs?
1 of 5 similar drugs in Interstitial Cystitis were approved
Approved (1) Terminated (2) Active (3)
✅Pentosan polysulfate sodium 100 mg + Placebo + Pentosan polysulfate sodium 100 mgJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00295854 | Phase 2 | Completed |
Competing Products
20 competing products in Interstitial Cystitis